NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Munafa technical analysis Intellia Therapeutics, Inc. NTLA technical analysis buy or sell

Munafa technical analysis Intellia Therapeutics, Inc. NTLA technical analysis buy or sell Analysis of Intellia Therapeutics, Inc. NTLA to buy or sell for Daily, weekly or monthly

Quick Chart Bull Charts Forecast Tomorrow Price Targets View Analysis

Intellia Therapeutics, Inc. NTLA Daily Analysis to buy or sell

As per my analysis of Intellia Therapeutics, Inc. NTLA, 12 day returns for Intellia Therapeutics, Inc. NTLA have been positive, with total returns of 0.33, which is 2.6% with investment starting at 12.69.
An investment of 100,000 bucks in Intellia Therapeutics, Inc. would have become 102600 bucks today.

Intellia Therapeutics, Inc. NTLA moves in a range of 0.4 points on a day to day basis. This means that a total of approx 0.4 plus points of returns can be expected in a bullish day, and a total of 0.4 minus points can be expected in a bearish day.
This is about 3.07% of returns per day.

Intellia Therapeutics, Inc. Munafa analysis, looking for Trend and BUY or SELL opportunities.

Stock is in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Intellia Therapeutics, Inc. NTLA at this time.

It appears as if Intellia Therapeutics, Inc. NTLA gave a large move recently.

Stock of Intellia Therapeutics, Inc. (NTLA) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

My analysis of Intellia Therapeutics, Inc. is bearish for shortterm, and stock might move down till 12.6 or till 11.8. Use a stoploss of 13.33 and if the stock hits stoploss, then it can shoot up till 14.04

You can find more Price Targets here or Forecast here for Shortterm, Midterm, and Longterm

Daily Candle Stick analysis of Intellia Therapeutics, Inc. NTLA

Candle stick analysis of Intellia Therapeutics, Inc. as on 03 Wed Jun 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 5.9 HC: 1.5 LC: 4.4 OC: 0.5

Intellia Therapeutics, Inc. is moving towards a high expiry

Intellia Therapeutics, Inc. is forming a DOJI candle

Candle stick analysis of Intellia Therapeutics, Inc. as on 02 Tue Jun 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 7.1 HC: 5 LC: 2 OC: 1.2

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 01 Mon Jun 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 5.7 HC: 3.1 LC: 2.5 OC: 3

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 29 Fri May 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 9 HC: 1.7 LC: 7.2 OC: 2.7

Intellia Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 28 Thu May 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 6 HC: 2.3 LC: 3.6 OC: 3.9

Intellia Therapeutics, Inc. is moving towards a high expiry

Intellia Therapeutics, Inc. NTLA Weekly Analysis to buy or sell

As per my analysis of Intellia Therapeutics, Inc. NTLA, 12 week returns for Intellia Therapeutics, Inc. NTLA have been positive, with total returns of 0.64, which is 5.17% with investment starting at 12.38.
An investment of 100,000 bucks in Intellia Therapeutics, Inc. would have become 105170 bucks today.

Intellia Therapeutics, Inc. NTLA moves in a range of 1 points on a week to week basis. This means that a total of approx 1 plus points of returns can be expected in a bullish week, and a total of 1 minus points can be expected in a bearish week.
This is about 7.68% of returns per week.

Weekly Candle Stick analysis of Intellia Therapeutics, Inc. NTLA

Candle stick analysis of Intellia Therapeutics, Inc. as on 03 Wed Jun 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 13.6 HC: 8.8 LC: 4.4 OC: 3

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 29 Fri May 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 16.8 HC: 1.7 LC: 14.9 OC: 12.9

Intellia Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 22 Fri May 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 17.7 HC: 10.2 LC: 6.9 OC: 0.7

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 15 Fri May 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 21 HC: 13.8 LC: 6.3 OC: 10.6

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 08 Fri May 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 11 HC: 3.3 LC: 7.5 OC: 9.9

Intellia Therapeutics, Inc. is moving towards a high expiry

Intellia Therapeutics, Inc. NTLA Monthly Analysis to buy or sell

As per my analysis of Intellia Therapeutics, Inc. NTLA, 12 month returns for Intellia Therapeutics, Inc. NTLA have been negative, with total returns of -0.58, which is -4.26% with investment starting at 13.60.
An investment of 100,000 bucks in Intellia Therapeutics, Inc. would have become 95740 bucks today.

Intellia Therapeutics, Inc. NTLA moves in a range of 2.6 points on a month to month basis. This means that a total of approx 2.6 plus points of returns can be expected in a bullish month, and a total of 2.6 minus points can be expected in a bearish month.
This is about 19.97% of returns per month.

Monthly Candle Stick analysis of Intellia Therapeutics, Inc. NTLA

Candle stick analysis of Intellia Therapeutics, Inc. as on 03 Wed Jun 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 13.6 HC: 8.8 LC: 4.4 OC: 3

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 29 Fri May 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 57.2 HC: 31.5 LC: 19.6 OC: 12.1

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 24 Fri Apr 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 46 HC: 24.6 LC: 17.2 OC: 37.3

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 27 Fri Mar 2026 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 28 HC: 25.3 LC: 2.2 OC: 12.5

Intellia Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Intellia Therapeutics, Inc. as on 27 Fri Feb 2026 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Intellia Therapeutics, Inc. are:
HL: 31.9 HC: 3.8 LC: 27.1 OC: 14.3

Intellia Therapeutics, Inc. is moving towards a high expiry

Share on: WhatsApp Facebook Tweet